
Sign up to save your podcasts
Or


In this episode of TDR Cannabis in Five, host Shadd Dales covers one of the biggest federal cannabis documents ever released: the 252-page report from HHS, originally submitted to the DEA in August 2023. The report recommended moving cannabis from Schedule I to Schedule III — and laid out detailed scientific evidence showing medical use, lower abuse potential, and clear public-health benefits compared to strict prohibition.Shadd breaks down what the report actually found: clinical evidence supporting medical use, the FDA’s eight-factor analysis, the risks and benefits the government acknowledged, and the economic and regulatory consequences rescheduling would trigger. The discussion cuts through noise and focuses on what the federal government put in writing — not speculation.The episode also touches on how the report could shape research access, banking, tax rules, pharmaceutical engagement, and long-term investor confidence. While rescheduling isn’t legalization, the shift away from “no medical use” is a major narrative pivot.The conclusion stays grounded: the report doesn’t guarantee anything, and DEA still holds the final decision. But the detail, tone, and scientific backing make it a foundational moment in modern cannabis policy. It’s worth understanding for anyone who follows the sector seriously.#HHSReport #CannabisRescheduling #ScheduleIII #CannabisScience #TDRCannabisInFive #ShaddDales #CannabisPolicy #CannabisResearch #MorganAndMorgan #CannabisIndustryWant to see more Cannabis Reform videos? • Three Months That Made Cannabis Impossible... • Three Months That Made Cannabis Impossible... • High Tide Executive Warns the Canadian Can... • Texas Moves Ahead Despite the Federal Ban ... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
By Dales Media Group5
88 ratings
In this episode of TDR Cannabis in Five, host Shadd Dales covers one of the biggest federal cannabis documents ever released: the 252-page report from HHS, originally submitted to the DEA in August 2023. The report recommended moving cannabis from Schedule I to Schedule III — and laid out detailed scientific evidence showing medical use, lower abuse potential, and clear public-health benefits compared to strict prohibition.Shadd breaks down what the report actually found: clinical evidence supporting medical use, the FDA’s eight-factor analysis, the risks and benefits the government acknowledged, and the economic and regulatory consequences rescheduling would trigger. The discussion cuts through noise and focuses on what the federal government put in writing — not speculation.The episode also touches on how the report could shape research access, banking, tax rules, pharmaceutical engagement, and long-term investor confidence. While rescheduling isn’t legalization, the shift away from “no medical use” is a major narrative pivot.The conclusion stays grounded: the report doesn’t guarantee anything, and DEA still holds the final decision. But the detail, tone, and scientific backing make it a foundational moment in modern cannabis policy. It’s worth understanding for anyone who follows the sector seriously.#HHSReport #CannabisRescheduling #ScheduleIII #CannabisScience #TDRCannabisInFive #ShaddDales #CannabisPolicy #CannabisResearch #MorganAndMorgan #CannabisIndustryWant to see more Cannabis Reform videos? • Three Months That Made Cannabis Impossible... • Three Months That Made Cannabis Impossible... • High Tide Executive Warns the Canadian Can... • Texas Moves Ahead Despite the Federal Ban ... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

30,178 Listeners

153,606 Listeners

9,572 Listeners

3,787 Listeners

82,211 Listeners

2,440 Listeners

12,463 Listeners

53 Listeners

2,116 Listeners

2,725 Listeners

40,288 Listeners

12,854 Listeners

109 Listeners

7 Listeners

14 Listeners